PubMed COVID-19 Clinical Care

The acute effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are well known; however, the long-term cardiopulmonary effects are less well characterized. The phenotypic expression of acute infection is heterogeneous, ranging from

CONCLUSION: While it is reassuring that most corresponding pre-prints could not be retrieved, our study highlights the need for online platforms and journals to employ quality assurance methods to prevent the spread of misinformation through citation

CONCLUSIONS AND IMPLICATIONS: To avoid decreasing satisfaction with meaningful activities, supporting older adults may be protective against the occurrence of depressive symptoms. Our findings highlight the need for health care professionals to not

While the message emanating from physiological and psychological research has extolled the general advantages of exercise in physical and cognitive health, the social distancing and the impossibility of group exercises have revealed more complex

CONCLUSION: For many children, adapting to virtual education has been challenging; therefore, parents should change their parenting control and support. The emergence of such challenges has led to the creation of more opportunities in the field of

CONCLUSION: In this multicenter study, we confirmed that AIRD patients treated with rituximab or corticosteroids and/or having vasculitis, auto-inflammatory disease, and sarcoidosis had increased risk of severe COVID-19. Also, AIRD patients had

CONCLUSION: The guidelines could not address seafarers' psychological needs to ensure their good health and wellbeing. Therefore, it is recommended that shipping companies address the mental health needs of seafarers during the COVID-19 pandemic and

No abstract

SARS-CoV-2 has significantly mutated its genome during the past 3 years, leading to the periodic emergence of several variants. Some of the variants possess enhanced fitness advantage, transmissibility, and pathogenicity and can also reduce vaccine

CONCLUSIONS: We developed a CAPA risk score as a noninvasive tool to aid in CAPA screening for patients with severe COVID-19. Our score will also identify a group of patients who are unlikely to have CAPA and who therefore need not undergo additional